Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Waksal Harlan
Relationship:  
City:   New Brunswick
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   3,342,716    

Indirect Shares

  0      
Direct Value   $2,260,845    

Indirect Value

  $0      
Total Shares   3,342,716      
Total Value   $2,260,845      


Eloxx Pharmaceuticals Inc
 $2,260,845 Lyra Therapeutics, Inc.
 $0 Eloxx Pharmaceuticals Inc
 $2,260,845 Lyra Therapeutics, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    2   
    0    

     Stock price went up :

    2   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   2.0   
   0.0   
     Percentage Gain/Loss :
   23.2%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Eloxx Pharmaceuticals Inc ELOX Director 2012-08-08 2,805,750 2009-07-29 0    Premium*  
            Kadmon Holdings, Llc KDMN President, CEO, Director 2021-11-09 0 0    Premium*  
            Lyra Therapeutics, Inc. LYRA 2024-03-18 536,966 2022-04-12 0    Premium*  
* Premium Members only  

Records found :    21         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
LYRA Lyra Therapeutics, Inc. Executive Chair   •       •      –    2024-03-18 4 A $0.00 $0 D/D 275,000 536,966 0 -
LYRA Lyra Therapeutics, Inc. Executive Chair   •       •      –    2023-11-10 4 B $2.96 $74,095 D/D 25,000 261,966 0.01 -
LYRA Lyra Therapeutics, Inc. Executive Chair   •       •      –    2022-04-12 4 B $4.22 $999,997 D/D 236,966 236,966 2.81 -
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2021-11-09 4 D $9.50 $1,690,478 D/D (177,945) 0 0 -
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2021-05-13 4 A $3.56 $88,978 D/D 25,000 177,945 0 -
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2020-03-13 4 B $2.93 $46,811 D/D 16,000 152,945 0.01 %
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2020-03-11 4 B $3.96 $49,859 D/D 12,600 136,945 0.01 %
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2019-03-29 4 A $2.25 $17,361 D/D 7,716 124,345 0 -
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2018-09-28 4 A $2.84 $16,705 D/D 5,882 116,629 0 -
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2017-08-10 4 B $2.27 $11,333 D/D 5,000 110,747 0.01 -
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2017-08-08 4 B $2.34 $8,667 D/D 3,707 105,747 0.01 -
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2016-11-16 4 B $6.37 $12,733 D/D 2,000 102,040 2.81 -
KDMN Kadmon Holdings, Llc President, CEO   •       •      –    2016-11-14 4 B $6.79 $13,580 D/D 2,000 100,040 0.01 -
KDMN Kadmon Holdings, Llc President, CEOOfficer   •       •      –    2016-07-26 3 IO $0.00 $0 D/D 0 98,040 -
ELOX Eloxx Pharmaceuticals Inc Director   –       •      –    2012-08-08 4 OE $0.26 $223,214 D/D 858,517 2,805,750 0 -
ELOX Eloxx Pharmaceuticals Inc Director   –       •      –    2012-01-06 4 B $0.26 $250,000 D/D 961,538 1,902,590 2.39 -
ELOX Eloxx Pharmaceuticals Inc Director   –       •      –    2010-05-25 4 A $0.37 $16,536 D/D 40,213 190,992 0 -
ELOX Eloxx Pharmaceuticals Inc Director   –       •      –    2010-05-25 4 OE $0.83 $523,876 D/D 631,176 822,168 0 -
ELOX Eloxx Pharmaceuticals Inc Director   –       •      –    2010-02-19 4 B $0.00 $0 D/D 135,779 150,779 2.31 -
ELOX Eloxx Pharmaceuticals Inc Director   –       •      –    2009-07-29 4 B $0.00 $0 D/D 27,188 27,188 2.31 -
ELOX Eloxx Pharmaceuticals Inc Director   –       •      –    2009-07-29 4 B $0.90 $13,500 D/D 15,000 15,000 2.39 -

  21  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed